Advertisement

Topics

Generics in Greece most expensive in the EU and uptake remain low

05:29 EDT 18 Aug 2017 | Generics and Biosimilars Initiative

Despite being one of Europe’s poorest countries, Greece continues to spend on expensive patented drugs and only a quarter of medicines prescribed in the country are generics, according to recent analysis by Politico.

Original Article: Generics in Greece most expensive in the EU and uptake remain low

NEXT ARTICLE

More From BioPortfolio on "Generics in Greece most expensive in the EU and uptake remain low"

Advertisement
Quick Search
Advertisement
Advertisement